In January 2026, Vir Biotechnology reported new positive data from its ongoing SOLSTICE Phase 2 trial in chronic hepatitis delta, where combination therapy with investigational agents tobevibart and ...

Shares Core Dividend ETF (DIVB): 2.4% yield, buybacks, low 14.8x P/E, and strong upside capture. Read here for a detailed ...

Learn everything you need to know about iShares Core High Dividend ETF (HDV) and how it ranks compared to other funds. Research performance, expense ratio, holdings, and volatility to see if it's the ...

Dividend ETFs with unusually high yields have become a core tool for investors who want their portfolios to spin off serious ...

Don't wait too long to make a decision on these three stocks.

The Schwab U.S. Dividend Equity ETF stands out for 2026, offering high yield and robust dividend growth potential as rates decline. See why I rate the stock a Strong Buy.

The Lakers have found their standard. The execution is the ultimate test. "Hopefully we can find that consistency," JJ Redick ...

BBC Sport's Ask Me Anything team explain if Antoine Semenyo can feature for Manchester City against Newcastle in the Carabao Cup semi-finals.

Explore how VIG and HDV differ in yield, sector focus, and risk—key factors for investors weighing income versus growth ...

VYM has delivered a stronger one-year return and holds a much broader mix of stocks than HDV. HDV sports a higher dividend yield and a greater tilt toward consumer defensive and energy sectors. VYM’s ...

SCHD is slightly cheaper to own and currently offers a higher dividend yield than HDV. HDV, however, has delivered bigger returns and a shallower five-year drawdown. Both funds have large exposure to ...